Mawer, DPC;
Eyre, DW;
Griffiths, D;
Fawley, WN;
Martin, JSH;
Quan, TP;
Peto, TEA;
... Wilcox, MH; + view all
(2017)
Contribution to Clostridium difficile transmission of symptomatic patients with toxigenic strains who are fecal toxin negative.
Clinical Infectious Diseases
, 64
(9)
pp. 1163-1170.
10.1093/cid/cix079.
Preview |
Text (Article)
Walker_revised_manuscript_20161209_clean.pdf - Accepted Version Download (754kB) | Preview |
Preview |
Text (Figure 1)
Walker_figure1.pdf Download (22kB) | Preview |
Preview |
Text (Figure 2)
Walker_figure2.pdf Download (11kB) | Preview |
Preview |
Text (Figure 3)
Walker_figure3.pdf Download (8kB) | Preview |
Abstract
Background: The role of symptomatic patients who are toxigenic strain-positive (TS+) but fecal toxin-negative (FT-) in transmission of Clostridium difficile is currently unknown. / Methods: We investigated the contribution of symptomatic TS+/FT- and TS+/FT+ patients in C. difficile transmission in two UK regions. From two-step testing, all glutamate dehydrogenase (GDH)-positive specimens, regardless of fecal toxin result, from Oxford (April2012-April2013) and Leeds (July2012-April2013) microbiology laboratories underwent culture and whole-genome sequencing (WGS), using WGS to identify toxigenic strains. Plausible sources for each TS+/FT+ case, including TS+/FT- and TS+/FT+ patients, were determined using WGS, with and without hospital admission data. / Results: 1447/12772(11%) fecal samples were GDH-positive, 866/1447(60%) contained toxigenic C. difficile and fecal toxin was detected in 511/866(59%), representing 235 Leeds and 191 Oxford TS+/FT+ cases. TS+/FT+ cases were three times more likely to be plausibly acquired from a previous TS+/FT+ case than a TS+/FT- patient. 51(19%) of 265 TS+/FT+ cases diagnosed >3 months into the study were genetically-related (≤2 single nucleotide polymorphisms) to ≥1 previous TS+/FT+ case or TS+/FT- patient: 27(10%) to only TS+/FT+ cases, 9(3%) to only TS+/FT- patients, and 15(6%) to both. Only 10/265(4%) were genetically-related to a previous TS+/FT+ or TS+/FT- patient and shared the same ward simultaneously or within 28 days. / Conclusions: Symptomatic TS+/FT- patients were a source of C. difficile transmission, although they accounted for less onward transmission than TS+/FT+ cases. Although transmission from symptomatic patients with either fecal toxin status accounted for a low overall proportion of new cases, both groups should be infection control targets.
| Type: | Article |
|---|---|
| Title: | Contribution to Clostridium difficile transmission of symptomatic patients with toxigenic strains who are fecal toxin negative |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1093/cid/cix079 |
| Publisher version: | https://doi.org/10.1093/cid/cix079 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Clostridium difficile; infection; fecal toxin; transmission |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > MRC Clinical Trials Unit at UCL |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1532871 |
Archive Staff Only
 |
View Item |
